Aridis Pharmaceuticals, Inc.
ARDSDelisted Sep 8, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001614067
Aridis Pharmaceuticals, Inc. was delisted on Sep 8, 2023; its insiders filed their last Form 4 on Jun 28, 2024; 18 institutions reported holding it in 13F filings for Q2 2023, worth $392.3K in total; no superinvestor held it.
Holders of 5% or more of ARDS
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Aridis Pharmaceuticals, Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Armistice Capital, LLC | 13G/A | 11.43%5.10M shares | 0.00 ppfrom 11.43% | Feb 14, 20254 filings | Feb 17, 2026 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
4 Schedule 13D and 13G filings on Aridis Pharmaceuticals, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Feb 17, 20269:51 PM ET | Armistice Capital, LLCand 1 other | 13G/A | 11.43%5.10M shares | 0.00 ppfrom 11.43% | Dec 31, 2025 | SEC |
| Aug 14, 20259:38 PM ET | Armistice Capital, LLCand 1 other | 13G/A | 11.43%5.10M shares | 0.00 ppfrom 11.43% | Jun 30, 2025 | SEC |
| May 15, 20253:22 PM ET | Armistice Capital, LLCand 1 other | 13G/A | 11.43%5.10M shares | 0.00 ppfrom 11.43% | Mar 31, 2025 | SEC |
| Feb 14, 20254:49 PM ET | Armistice Capital, LLCand 1 other | 13G/A | 11.43%5.10M shares | – | Dec 31, 2024 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Aridis Pharmaceuticals, Inc. shares.
No Form 144 notices for Aridis Pharmaceuticals, Inc. are on file.